Buscar
Mostrando ítems 1-10 de 81
Separation of human Fab fragments on negative mode Ni(II)-TREN-agarose chromatography
(Elsevier Sci LtdOxfordInglaterra, 2014)
Separation Of Human Fab Fragments By Negative Chromatography On Omega-aminohexyl- And Poly(ethyleneimine)-agarose
(Elsevier Sci LtdOxford, 2017)
F(ab')2 antibody fragments against Trypanosoma cruzi calreticulin inhibit its interaction with the first component of human complement
(Sociedad de Biología de Chile, 2005)
Separation Of Human Igg Fragments Using Copper, Nickel, Zinc, And Cobalt Chelated To Cm-asp-agarose By Positive And Negative Chromatography
(ELSEVIER SCIENCE BVAMSTERDAM, 2016)
Separation Of Human Igg Fragments Using Copper, Nickel, Zinc, And Cobalt Chelated To Cm-asp-agarose By Positive And Negative Chromatography
(Elsevier Science BVAmsterdam, 2016)
Human recombinant fab fragment neutralizes shiga toxin type 2 cytotoxic effects in vitro and in vivo
(MDPI, 2018-12)
Shiga toxin (Stx) producing Escherichia coli (STEC) is responsible for causing hemolytic uremic syndrome (HUS), a life-threatening thrombotic microangiopathy characterized by thrombocytopenia, hemolytic anemia, and acute ...
Pharmacokinetic-pharmacodynamic relationships of immunoglobulin therapy for envenomation.
(2003-07)
Parenteral administration of horse- and sheep-derived antivenoms constitutes the cornerstone in the therapy of envenomations induced by animal bites and stings. Depending on the type of neutralising molecule, antivenoms ...
Pharmacokinetic-pharmacodynamic relationships of immunoglobulin therapy for envenomation.
(2003-07)
Parenteral administration of horse- and sheep-derived antivenoms constitutes the cornerstone in the therapy of envenomations induced by animal bites and stings. Depending on the type of neutralising molecule, antivenoms ...
F(ab)(2) antibody fragments against trypanosoma cruzi calreticulin inhibit its interaction with the first component of human complement
(SOCIEDAD DE BIOLOGIA DE CHILE, 2005)
F(ab )2 antibody fragments against trypanosoma cruzi calreticulin inhibit its interaction with the first component of human complement
(SOCIEDAD DE BIOLOGIA DE CHILE, 2005)